https://www.vesper-ventures.com/pt/post/terapia-viral-oncolítica-entrevista-com-a-startup-vyro-biotherapeutics 2023-03-03 https://static.wixstatic.com/media/7532e0_ffdb5a7657c24792aacde2dd8287ad6b~mv2.jpeg https://www.vesper-ventures.com/pt/post/crispr-a-técnica-que-está-revolucionando-a-agricultura-e-a-saúde-humana-1 2023-02-09 https://static.wixstatic.com/media/7532e0_31f35865987e4971bea62f6c2250a6b4~mv2.jpg https://www.vesper-ventures.com/pt/post/agricultura-de-precisão-como-atender-as-necessidades-do-campo 2023-02-23 https://static.wixstatic.com/media/7532e0_3c53d95c6637476f9b942b86e0fbb60f~mv2.jpg https://www.vesper-ventures.com/pt/post/como-a-biologia-sintética-moldará-o-futuro 2023-01-12 https://static.wixstatic.com/media/7532e0_2b5f9c7695ec41cba4719f34f3d1484e~mv2.jpeg https://www.vesper-ventures.com/pt/post/regenerar-para-curar-o-potencial-da-terapia-regenerativa 2023-03-10 https://static.wixstatic.com/media/7532e0_7729cd34327a4475a21cf8fa4e826c4f~mv2.png https://www.vesper-ventures.com/pt/post/células-car-t-a-reprogramação-celular-no-tratamento-do-câncer 2023-02-10 https://static.wixstatic.com/media/7532e0_5757f09f417347f6860685973fd6fed2~mv2.png https://www.vesper-ventures.com/pt/post/vacina-de-rna-o-elo-entre-o-material-genético-e-a-resposta-imunológica-2 2022-12-20 https://static.wixstatic.com/media/d24611_d354d35ed0824632b02abee54386a63f~mv2.png https://www.vesper-ventures.com/pt/post/biotechs-da-pesquisa-científica-ao-negócio-1 2023-03-23 https://static.wixstatic.com/media/7532e0_bf38e289647e41f4adb75e126869a18b~mv2.png